Chapter 18: Practical Applications of Immunology – Vaccines and Immunological Diagnostics

Applications of Immunology

History of Vaccines and Variolation

Vaccination and variolation are foundational practices in immunology, aimed at preventing infectious diseases by stimulating the immune system.

• Variolation: An early method of immunization involving the deliberate introduction of material from smallpox sores into the skin, used before the development of modern vaccines.

• Vaccination: Introduced by Edward Jenner in 1796, using cowpox virus to confer immunity to smallpox. This led to the development of vaccines for various diseases.

• Impact: Vaccination has drastically reduced the incidence of many infectious diseases worldwide.

Vaccination and Immune Response

Vaccines exploit the body's natural immune response to provide protection against pathogens.

• Primary Immune Response: The initial response to an antigen, characterized by a lag phase and the production of IgM antibodies, followed by IgG.

• Secondary Immune Response: Upon re-exposure to the same antigen, the immune system responds more rapidly and robustly, primarily with IgG antibodies, due to memory cells.

• Effect of Vaccination: Vaccines mimic infection, inducing memory cells and preparing the immune system for future exposures.

Herd Immunity

Herd immunity refers to the indirect protection from infectious diseases that occurs when a large percentage of a population becomes immune.

• Definition: When enough individuals are immune, the spread of contagious disease is minimized, protecting those who are not immune.

• Public Health Implications: Achieving herd immunity through vaccination can prevent outbreaks and protect vulnerable populations.

Types of Vaccines

Vaccines are classified based on their composition and method of preparation. Each type has specific advantages and disadvantages.

• Live Attenuated Vaccines: Contain weakened forms of the pathogen that replicate in the host without causing disease in healthy individuals.

  • Advantages: Strong, long-lasting immunity; often requires fewer doses.

  • Disadvantages: Risk of reversion to virulence; not suitable for immunocompromised individuals.

  • Examples: Measles, mumps, rubella (MMR) vaccine.

• Inactivated (Killed) Vaccines: Contain pathogens that have been killed by heat or chemicals.

  • Advantages: Cannot cause disease; safer for immunocompromised individuals.

  • Disadvantages: Weaker immune response; may require booster shots.

  • Examples: Inactivated polio vaccine.

• Subunit Vaccines: Contain only specific antigens from the pathogen.

  • Recombinant DNA Vaccines: Antigens produced by genetic engineering.

  • Virus-like Particle (VLP) Vaccines: Contain molecules that mimic the structure of viruses but lack genetic material.

  • Toxoid Vaccines: Contain inactivated toxins (toxoids) produced by the pathogen.

  • Advantages: Fewer side effects; focused immune response.

  • Disadvantages: May require adjuvants and booster doses.

  • Examples: Hepatitis B (recombinant), HPV (VLP), DTaP (toxoid).

• Conjugated Vaccines: Combine weak antigens with strong protein carriers to enhance immune response.

  • Example: Haemophilus influenzae type b (Hib) vaccine.

• Nucleic Acid Vaccines: Use DNA or mRNA encoding the antigen to induce immunity.

  • Advantages: Rapid development; strong cellular and humoral responses.

  • Examples: COVID-19 mRNA vaccines (Pfizer-BioNTech, Moderna).

Vaccine Adjuvants

Adjuvants are substances added to vaccines to enhance the body's immune response to the antigen.

• Purpose: Increase immunogenicity, especially in inactivated and subunit vaccines.

• Examples: Aluminum salts (alum) are common adjuvants.

New Vaccine Technologies

Recent advances have led to novel vaccine platforms and delivery methods.

• mRNA Vaccines: Use messenger RNA to instruct cells to produce antigenic proteins.

• Viral Vector Vaccines: Use harmless viruses to deliver genetic material encoding antigens.

• Edible Vaccines: Experimental vaccines produced in genetically modified plants.

Vaccine Safety

Vaccine safety is a topic of ongoing research and public discussion.

• Monitoring: Vaccines undergo rigorous testing for safety and efficacy before approval.

• Controversies: Concerns about side effects and misinformation can affect public confidence.

• Benefit-Risk Analysis: The benefits of vaccination in preventing disease far outweigh the risks of rare adverse events.

Antibody-Antigen Complexes in Diagnostics and Treatment

Antibody-antigen interactions are central to many immunological diagnostic tests and therapies.

• Diagnostic Use: Detection of specific antibodies or antigens in patient samples.

• Treatment: Monoclonal antibodies can neutralize pathogens or toxins.

Sensitivity and Specificity in Diagnostic Tests

Diagnostic tests are evaluated based on their sensitivity and specificity.

• Sensitivity: The ability of a test to correctly identify those with the disease (true positives).

• Specificity: The ability of a test to correctly identify those without the disease (true negatives).

• Example: A highly sensitive HIV test detects nearly all infected individuals, while a highly specific test minimizes false positives.

Monoclonal Antibodies: Development and Uses

Monoclonal antibodies are laboratory-produced molecules engineered to bind to specific antigens.

• Development: Produced by hybridoma technology, fusing an antibody-producing B cell with a myeloma cell.

• Diagnostic Uses: Pregnancy tests, detection of pathogens.

• Therapeutic Uses: Treatment of cancers, autoimmune diseases, and infectious diseases.

Agglutination Reactions

Agglutination tests detect the clumping of particles, indicating the presence of specific antigens or antibodies.

• Direct Agglutination: Antibodies react with antigens on the surface of cells or particles.

• Indirect (Passive) Agglutination: Antigens or antibodies are attached to particles (e.g., latex beads) to enhance visibility.

• Hemagglutination: Agglutination of red blood cells, used in blood typing and viral detection.

• Titer: The concentration of antibodies; a rising titer indicates active infection, while a stable or decreasing titer suggests recovery or past exposure.

Neutralization Reactions

Neutralization tests measure the ability of antibodies to block the biological activity of pathogens or toxins.

• Application: Used to confirm immunity or diagnose infections (e.g., viral neutralization tests).

ELISA (Enzyme-Linked Immunosorbent Assay)

ELISA is a sensitive and versatile technique for detecting and quantifying antigens or antibodies.

• Benefits: High sensitivity and specificity; suitable for large-scale screening.

• Direct ELISA: Detects antigens using a labeled antibody that binds directly to the target.

• Indirect ELISA: Detects antibodies by using an antigen-coated surface and a labeled secondary antibody.

• Procedure:

  1. Coat plate with antigen or antibody.

  2. Add sample (containing antibody or antigen).

  3. Add enzyme-linked secondary antibody.

  4. Add substrate; enzyme reaction produces a detectable signal (color change).

Table: Comparison of Vaccine Types

Vaccine Type	Main Feature	Advantages	Disadvantages	Examples
Live Attenuated	Weakened live pathogen	Strong, long-lasting immunity	Risk for immunocompromised; rare reversion	MMR, Varicella
Inactivated	Killed pathogen	Safe, stable	Weaker response; boosters needed	Inactivated polio, Hepatitis A
Subunit	Purified antigen	Fewer side effects	May need adjuvant/boosters	Hepatitis B, HPV
Conjugated	Antigen + protein carrier	Enhanced response in children	Complex production	Hib
Nucleic Acid	DNA or mRNA encoding antigen	Rapid development, strong response	New technology; long-term data limited	COVID-19 mRNA vaccines

Table: Sensitivity vs. Specificity

Term	Definition	Formula	Example
Sensitivity	True positive rate	$\text{Sensitivity} = \frac{\text{True Positives}}{\text{True Positives} + \text{False Negatives}}$	Detecting all HIV-positive patients
Specificity	True negative rate	$\text{Specificity} = \frac{\text{True Negatives}}{\text{True Negatives} + \text{False Positives}}$	Correctly excluding HIV-negative patients

Additional info: Academic context and examples have been added to expand on the brief points in the original material, ensuring the notes are self-contained and suitable for exam preparation.